Using Geographic Catchment Areas to Measure Population-based Access to Kidney Transplant in the United States.


Journal

Transplantation
ISSN: 1534-6080
Titre abrégé: Transplantation
Pays: United States
ID NLM: 0132144

Informations de publication

Date de publication:
12 2020
Historique:
entrez: 20 11 2020
pubmed: 21 11 2020
medline: 9 2 2021
Statut: ppublish

Résumé

Monitoring efforts to improve access to transplantation requires a definition of the population attributable to a transplant center. Previously, assessment of variation in transplant care has focused on differences between administrative units-such as states-rather than units derived from observed care patterns. We defined catchment areas (transplant referral regions [TRRs]) from transplant center care patterns for population-based assessment of transplant access. We used US adult transplant listings (2006-2016) and Dartmouth Atlas catchment areas to assess the optimal method of defining TRRs. We used US Renal Data System and Scientific Registry of Transplant Recipient data to compare waitlist- and population-based kidney transplant rates. We identified 110 kidney, 67 liver, 85 pancreas, 68 heart, and 43 lung TRRs. Most patients were listed in their assigned TRR (kidney: 76%; liver: 75%; pancreas: 75%; heart: 74%; lung: 72%), although the proportion varied by organ (interquartile range for kidney, 65.7%-82.5%; liver, 58.2%-78.8%; pancreas, 58.4%-81.1%; heart, 63.1%-80.9%; lung, 61.6%-76.3%). Patterns of population- and waitlist-based kidney transplant rates differed, most notably in the Northeast and Midwest. Patterns of TRR-based kidney transplant rates differ from waitlist-based rates, indicating that current metrics may not reflect transplant access in the broader population. TRRs define populations served by transplant centers and could enable future studies of how transplant centers can improve access for patients in their communities.

Sections du résumé

BACKGROUND
Monitoring efforts to improve access to transplantation requires a definition of the population attributable to a transplant center. Previously, assessment of variation in transplant care has focused on differences between administrative units-such as states-rather than units derived from observed care patterns. We defined catchment areas (transplant referral regions [TRRs]) from transplant center care patterns for population-based assessment of transplant access.
METHODS
We used US adult transplant listings (2006-2016) and Dartmouth Atlas catchment areas to assess the optimal method of defining TRRs. We used US Renal Data System and Scientific Registry of Transplant Recipient data to compare waitlist- and population-based kidney transplant rates.
RESULTS
We identified 110 kidney, 67 liver, 85 pancreas, 68 heart, and 43 lung TRRs. Most patients were listed in their assigned TRR (kidney: 76%; liver: 75%; pancreas: 75%; heart: 74%; lung: 72%), although the proportion varied by organ (interquartile range for kidney, 65.7%-82.5%; liver, 58.2%-78.8%; pancreas, 58.4%-81.1%; heart, 63.1%-80.9%; lung, 61.6%-76.3%). Patterns of population- and waitlist-based kidney transplant rates differed, most notably in the Northeast and Midwest.
CONCLUSIONS
Patterns of TRR-based kidney transplant rates differ from waitlist-based rates, indicating that current metrics may not reflect transplant access in the broader population. TRRs define populations served by transplant centers and could enable future studies of how transplant centers can improve access for patients in their communities.

Identifiants

pubmed: 33215901
doi: 10.1097/TP.0000000000003369
pii: 00007890-202012000-00020
doi:

Types de publication

Comparative Study Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e342-e350

Références

Thomas E, Milton J, Cigarroa FG. The Advancing American Kidney Health Executive Order: an opportunity to enhance organ donation. JAMA. 2019; 322:1645–1646. doi: 10.1001/jama.2019.14500
doi: 10.1001/jama.2019.14500
Mathur AK, Ashby VB, Fuller DS, et al. Variation in access to the liver transplant waiting list in the United States. Transplantation. 2014; 98:94–99. doi: 10.1097/01.TP.0000443223.89831.85
doi: 10.1097/01.TP.0000443223.89831.85
Alexander GC, Sehgal AR; Transplant Task Force of The Renal Network Inc, Inc. Variation in access to kidney transplantation across dialysis facilities: using process of care measures for quality improvement. Am J Kidney Dis. 2002; 40:824–831. doi: 10.1053/ajkd.2002.35695
doi: 10.1053/ajkd.2002.35695
Patzer RE, Perryman JP, Schrager JD, et al. The role of race and poverty on steps to kidney transplantation in the Southeastern United States. Am J Transplant. 2012; 12:358–368. doi: 10.1111/j.1600-6143.2011.03927.x
doi: 10.1111/j.1600-6143.2011.03927.x
Tonelli M, Klarenbach S, Rose C, et al. Access to kidney transplantation among remote- and rural-dwelling patients with kidney failure in the United States. JAMA. 2009; 301:1681–1690. doi: 10.1001/jama.2009.545
doi: 10.1001/jama.2009.545
Yu JC, Neugut AI, Wang S, et al. Racial and insurance disparities in the receipt of transplant among patients with hepatocellular carcinoma. Cancer. 2010; 116:1801–1809. doi: 10.1002/cncr.24936
doi: 10.1002/cncr.24936
Patzer RE, Amaral S, Wasse H, et al. Neighborhood poverty and racial disparities in kidney transplant waitlisting. J Am Soc Nephrol. 2009; 20:1333–1340. doi: 10.1681/ASN.2008030335
doi: 10.1681/ASN.2008030335
Patzer RE, Plantinga LC, Paul S, et al. Variation in dialysis facility referral for kidney transplantation among patients with end-stage renal disease in Georgia. JAMA. 2015; 314:582–594. doi: 10.1001/jama.2015.8897
doi: 10.1001/jama.2015.8897
Patzer RE, Paul S, Plantinga L, et al.; Southeastern Kidney Transplant Coalition. A randomized trial to reduce disparities in referral for transplant evaluation. J Am Soc Nephrol. 2017; 28:935–942. doi: 10.1681/ASN.2016030320
doi: 10.1681/ASN.2016030320
Centers for Medicare & Medicaid Services (CMS), HHS. Medicare Program; End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) Competitive Bidding Program (CBP) and fee schedule amounts, and technical amendments to correct existing regulations related to the CBP for certain DMEPOS. Final rule. Fed Regist. 2018; 83:56922–57073
Patzer RE. Quality metrics in transplantation—a new emphasis on transplant access. Am J Transplant. 2018; 18:1301–1302. doi: 10.1111/ajt.14764
doi: 10.1111/ajt.14764
Schaffhausen CR, Bruin MJ, Chu S, et al. The importance of transplant program measures: Surveys of three national patient advocacy groups. Clin Transplant. 2018; 32:e13426. doi: 10.1111/ctr.13426
doi: 10.1111/ctr.13426
Wennberg JE. The Center for the Evaluative Clinical Sciences DMS. The Dartmouth Atlas of Health Care in the United States. 1996. Chicago, IL: American Hospital Publishing
Axelrod DA, Lentine KL, Xiao H, et al. Accountability for end-stage organ care: implications of geographic variation in access to kidney transplantation. Surgery. 2014; 155:734–742. doi: 10.1016/j.surg.2013.12.010
doi: 10.1016/j.surg.2013.12.010
Kasiske BL, Wey A, Salkowski N, et al. Seeking new answers to old questions about public reporting of transplant program performance in the United States. Am J Transplant. 2019; 19:317–323. doi: 10.1111/ajt.15051
doi: 10.1111/ajt.15051
Axelrod DA, Guidinger MK, Finlayson S, et al. Rates of solid-organ wait-listing, transplantation, and survival among residents of rural and urban areas. JAMA. 2008; 299:202–207. doi: 10.1001/jama.2007.50
doi: 10.1001/jama.2007.50
Couchoud C, Bayat S, Villar E, et al.; REIN registry. A new approach for measuring gender disparity in access to renal transplantation waiting lists. Transplantation. 2012; 94:513–519. doi: 10.1097/TP.0b013e31825d156a
doi: 10.1097/TP.0b013e31825d156a
Axelrod DA. Balancing accountable care with risk aversion: transplantation as a model. Am J Transplant. 2013; 13:7–8. doi: 10.1111/j.1600-6143.2012.04346.x
doi: 10.1111/j.1600-6143.2012.04346.x
Schold JD, Phelan MP, Buccini LD. Utility of ecological risk factors for evaluation of transplant center performance. Am J Transplant. 2017; 17:617–621. doi: 10.1111/ajt.14074
doi: 10.1111/ajt.14074
OPTN/UNOS Liver and Intestine Transplantation Committee. Liver and intestine distribution using distance from donor hospital: briefing paper. Available at https://optn.transplant.hrsa.gov/media/2766/liver_boardreport_201812.pdf. Accessed June 16, 2020
Kidney Transplantation Committee & Pancreas Transplantation Committee. Eliminate the use of DSAs and regions from kidney and pancrease distribution. Available at https://optn.transplant.hrsa.gov/governance/public-comment/eliminate-the-use-of-dsas-and-regions-from-kidney-and-pancreas-distribution/. Accessed June 16, 2020
Hippen BE, Maddux FW. A house united: a reply to “Transplantation in Value-Based Care for Patients With Renal Failure”. Am J Transplant. 2018; 18:2096–2097. doi: 10.1111/ajt.14896
doi: 10.1111/ajt.14896

Auteurs

Katherine Ross-Driscoll (K)

Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA.
Emory Transplant Center, Emory University School of Medicine, Atlanta, GA.
Department of Medicine and Surgery, Health Services Research Center, Emory University School of Medicine, Atlanta, GA.

David Axelrod (D)

Department of Surgery, University of Iowa, Iowa City, IA.

Raymond Lynch (R)

Emory Transplant Center, Emory University School of Medicine, Atlanta, GA.
Department of Medicine and Surgery, Health Services Research Center, Emory University School of Medicine, Atlanta, GA.

Rachel E Patzer (RE)

Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA.
Emory Transplant Center, Emory University School of Medicine, Atlanta, GA.
Department of Medicine and Surgery, Health Services Research Center, Emory University School of Medicine, Atlanta, GA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH